Trends in the management of stage 3 retinopathy of prematurity.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 8703873.
- Also identified by PMC identifier 505448.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical outcome of 66 consecutive infants with stage 3 retinopathy of prematurity (ROP) is reported. Thirty four infants (64 eyes) were treated with cryotherapy and 32 infants (59 eyes) underwent laser photocoagulation. Infants with anterior-mid zone II ROP had a high rate of disease regression whether treated by cryotherapy or laser photocoagulation. Infants with posterior zone II or zone I ROP had a 40% success rate with cryotherapy, and 87.5% when treated with laser photocoagulation. Evolving experience and changing management policies in infants with posterior ROP has led to improved results.
Medical subject headings
- Cryotherapy
- Retinopathy of Prematurity